Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway

Caroline Hwang; Kelly Issokson; Catherine Giguere-Rich; Swapna Reddy; Andrew Tinsley; Welmoed K. Van Deen; Harry Bray; Donald Lum; Humberto Aguilar; Timothy L. Zisman; Ziad Younes; Damara Crate; Ridhima Oberai; Alandra Weaver; Gil Melmed; Corey Siegel; Jason K. Hou

doi:10.1016/j.cgh.2020.06.039

Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway

Caroline Hwang, Kelly Issokson, Catherine Giguere-Rich, Swapna Reddy, Andrew Tinsley, Welmoed K. Van Deen, Harry Bray, Donald Lum, Humberto Aguilar, Timothy L. Zisman, Ziad Younes, Damara Crate, Ridhima Oberai, Alandra Weaver, Gil Melmed, Corey Siegel, Jason K. Hou

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	2645-2649.e4
Journal	Clinical Gastroenterology and Hepatology
Volume	18
Issue number	12
DOIs	https://doi.org/10.1016/j.cgh.2020.06.039
State	Published - Nov 2020

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology

Access to Document

10.1016/j.cgh.2020.06.039

Cite this

Hwang, C., Issokson, K., Giguere-Rich, C., Reddy, S., Tinsley, A., Van Deen, W. K., Bray, H., Lum, D., Aguilar, H., Zisman, T. L., Younes, Z., Crate, D., Oberai, R., Weaver, A., Melmed, G., Siegel, C., & Hou, J. K. (2020). Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway. Clinical Gastroenterology and Hepatology, 18(12), 2645-2649.e4. https://doi.org/10.1016/j.cgh.2020.06.039

Hwang, Caroline ; Issokson, Kelly ; Giguere-Rich, Catherine ; Reddy, Swapna ; Tinsley, Andrew ; Van Deen, Welmoed K. ; Bray, Harry ; Lum, Donald ; Aguilar, Humberto ; Zisman, Timothy L. ; Younes, Ziad ; Crate, Damara ; Oberai, Ridhima ; Weaver, Alandra ; Melmed, Gil ; Siegel, Corey ; Hou, Jason K. / Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway. In: Clinical Gastroenterology and Hepatology. 2020 ; Vol. 18, No. 12. pp. 2645-2649.e4.

@article{ee5c1a422e7c49ab92416dcaaa65c517,

title = "Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway",

author = "Caroline Hwang and Kelly Issokson and Catherine Giguere-Rich and Swapna Reddy and Andrew Tinsley and {Van Deen}, {Welmoed K.} and Harry Bray and Donald Lum and Humberto Aguilar and Zisman, {Timothy L.} and Ziad Younes and Damara Crate and Ridhima Oberai and Alandra Weaver and Gil Melmed and Corey Siegel and Hou, {Jason K.}",

note = "Funding Information: Funding The Crohn's and Colitis Foundation supported this study with funding from Nestl? Health Science. The research reported here was supported in part with resources at the Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413) at the Michael E. DeBakey VA Medical Center, Houston, Texas. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs. Funding Information: Conflicts of interest These authors disclose the following: Jason K. Hou has received research funding from Redhill Biosciences, Janssen, AbbVie, Celgene, Genentech, Eli Lilly, Lycera, and Pfizer; and served as a consultant for AbbVie, Janssen, and Pfizer. Corey Siegel has served as a consultant for AbbVie, Amgen, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Takeda, UCB; Speaker for CME activities for American Regent, AbbVie, Janssen, Pfizer, Takeda; grant support from AbbVie, Janssen, Pfizer and Takeda. Gil Melmed has served as a consultant for AbbVie, Boehringer-Ingelheim, Celgene, Covance, Genentech, Janssen, Luitpold, Medtronic, Merck, Takeda, Pfizer, Samsung Bioepis, and UCB; and has received research funding from Pfizer. Ziad Younes has received speaking honoraria from Takeda, AbbVie, Pfizer. Research support: AbbVie, Gilead, Takeda, Celgene, Shire, Eli Lilly, Pfizer, and Genentech. Donald Lum has served on the Speakers Bureau for AbbVie and Takeda. Ridhima Oberai and Alandra Weaver are employees of the Crohn{\textquoteright}s and Colitis Foundation. Kelly Issokson has served a speaker for CME activities for Orgain Inc, RMEI, Medscape, and Crohn{\textquoteright}s and Colitis Foundation. Timothy L. Zisman has received research funding from AbbVie, Eli Lilly, Pfizer, and Takeda. The remaining authors disclose no conflicts. Funding Information: Funding The Crohn's and Colitis Foundation supported this study with funding from Nestl{\'e} Health Science. The research reported here was supported in part with resources at the Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413) at the Michael E. DeBakey VA Medical Center, Houston, Texas. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs. ",

year = "2020",

month = nov,

doi = "10.1016/j.cgh.2020.06.039",

language = "English (US)",

volume = "18",

pages = "2645--2649.e4",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "12",

}

Hwang, C, Issokson, K, Giguere-Rich, C, Reddy, S, Tinsley, A, Van Deen, WK, Bray, H, Lum, D, Aguilar, H, Zisman, TL, Younes, Z, Crate, D, Oberai, R, Weaver, A, Melmed, G, Siegel, C & Hou, JK 2020, 'Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway', Clinical Gastroenterology and Hepatology, vol. 18, no. 12, pp. 2645-2649.e4. https://doi.org/10.1016/j.cgh.2020.06.039

Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway. / Hwang, Caroline; Issokson, Kelly; Giguere-Rich, Catherine; Reddy, Swapna; Tinsley, Andrew; Van Deen, Welmoed K.; Bray, Harry; Lum, Donald; Aguilar, Humberto; Zisman, Timothy L.; Younes, Ziad; Crate, Damara; Oberai, Ridhima; Weaver, Alandra; Melmed, Gil; Siegel, Corey; Hou, Jason K.

In: Clinical Gastroenterology and Hepatology, Vol. 18, No. 12, 11.2020, p. 2645-2649.e4.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway

AU - Hwang, Caroline

AU - Issokson, Kelly

AU - Giguere-Rich, Catherine

AU - Reddy, Swapna

AU - Tinsley, Andrew

AU - Van Deen, Welmoed K.

AU - Bray, Harry

AU - Lum, Donald

AU - Aguilar, Humberto

AU - Zisman, Timothy L.

AU - Younes, Ziad

AU - Crate, Damara

AU - Oberai, Ridhima

AU - Weaver, Alandra

AU - Melmed, Gil

AU - Siegel, Corey

AU - Hou, Jason K.

N1 - Funding Information: Funding The Crohn's and Colitis Foundation supported this study with funding from Nestl? Health Science. The research reported here was supported in part with resources at the Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413) at the Michael E. DeBakey VA Medical Center, Houston, Texas. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs. Funding Information: Conflicts of interest These authors disclose the following: Jason K. Hou has received research funding from Redhill Biosciences, Janssen, AbbVie, Celgene, Genentech, Eli Lilly, Lycera, and Pfizer; and served as a consultant for AbbVie, Janssen, and Pfizer. Corey Siegel has served as a consultant for AbbVie, Amgen, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Takeda, UCB; Speaker for CME activities for American Regent, AbbVie, Janssen, Pfizer, Takeda; grant support from AbbVie, Janssen, Pfizer and Takeda. Gil Melmed has served as a consultant for AbbVie, Boehringer-Ingelheim, Celgene, Covance, Genentech, Janssen, Luitpold, Medtronic, Merck, Takeda, Pfizer, Samsung Bioepis, and UCB; and has received research funding from Pfizer. Ziad Younes has received speaking honoraria from Takeda, AbbVie, Pfizer. Research support: AbbVie, Gilead, Takeda, Celgene, Shire, Eli Lilly, Pfizer, and Genentech. Donald Lum has served on the Speakers Bureau for AbbVie and Takeda. Ridhima Oberai and Alandra Weaver are employees of the Crohn’s and Colitis Foundation. Kelly Issokson has served a speaker for CME activities for Orgain Inc, RMEI, Medscape, and Crohn’s and Colitis Foundation. Timothy L. Zisman has received research funding from AbbVie, Eli Lilly, Pfizer, and Takeda. The remaining authors disclose no conflicts. Funding Information: Funding The Crohn's and Colitis Foundation supported this study with funding from Nestlé Health Science. The research reported here was supported in part with resources at the Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413) at the Michael E. DeBakey VA Medical Center, Houston, Texas. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs.

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85091252307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091252307&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2020.06.039

DO - 10.1016/j.cgh.2020.06.039

M3 - Article

C2 - 32599016

AN - SCOPUS:85091252307

VL - 18

SP - 2645-2649.e4

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 12

ER -

Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this